Peptide questions · Mazdutide
How long does mazdutide take to work?
Reviewed Evidence: EstablishedPublished by PepVault
Mazdutide’s onset is days–2 weeks, its peak effect comes at 48–60 weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
The timeline’s basis: Phase 3 trials (GLORY-1, GLORY-2, DREAMS-1, DREAMS-2) and the Chinese label (Xinermei, NMPA 2025). Not FDA-approved.
Mazdutide week by week
The library places six of its research notes on mazdutide on the days they cover, from day 1 to day 336 and on: 5 on randomized trials and 1 on clinical data.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | Appetite first, scale later | Randomized trial |
| Days 29–56 (weeks 5–8) | A maintenance dose, not just a step | Randomized trial |
| Days 57–224 (weeks 9–32) | Holding at 4 mg | Randomized trial |
| Days 57–224 (weeks 9–32) | The top labelled dose | Randomized trial |
| Days 225–336 (weeks 33–48) | Weeks 32 to 48: still moving, more slowly | Randomized trial |
| From day 337 on | A maintenance medication, not a course | Clinical data |

Model. Individual results vary.
The mazdutide timeline’s milestones
The library’s timeline for mazdutide marks 6 points from week 1 to week 48, backed by clinical trial data overall.
- Week 1: Commonly reported: appetite dropping within days, with nausea most likely in the day or two after the injection
- Week 4: The label's first step: 2 mg for weeks 1 to 4, then 4 mg
- Week 8: The label's second step: 4 mg to stay on, or 6 mg from week 9 if more weight loss is needed
- Week 12: Commonly reported: GI side effects settling once the dose holds steady; in GLORY-1 they fell during maintenance
- Week 32: GLORY-1's main readout: about 10% (4 mg) and 12.5% (6 mg) average loss
- Week 48: GLORY-1's end: about 11% (4 mg) and 14% (6 mg) average loss, still falling slowly
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why mazdutide takes that long
Mazdutide’s half-life is about 10 days (240 hours), so one dose is about 96.9% cleared after 50 days.
On its schedule (Weekly) the doses overlap, and the level of mazdutide keeps climbing for about 40–50 days before it levels off, so the first 40–50 days run below the level the later weeks hold.
The notes on mazdutide follow the trials’ dose steps, 2mg, 4mg and 6mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Mazdutide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, mazdutide among them; 15 of the others share its onset of days–2 weeks.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does mazdutide take to work?
Mazdutide’s onset is days–2 weeks, its peak effect comes at 48–60 weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
When does mazdutide reach its peak effect?
By the library’s timeline, mazdutide’s peak effect comes at 48–60 weeks, backed by clinical trial data.
How long is mazdutide usually run?
The library’s timeline gives mazdutide’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials and label.
What does the library say about the first days on mazdutide?
Its first note on mazdutide, for days 1–28 (weeks 1–4), is “Appetite first, scale later”, resting on randomized trials.